80 Rogers Corp., a holding company established after OncogeneScience Inc. of Manhasset, N.Y., bought Applied Biotechnologylast year, on Wednesday reported to the Securities andExchange Commission the sale of 332,450 shares of Oncogenestock. 80 Rogers retains 1.6 million shares, a 10.7 percent stakein Oncogene. The company sold the shares between Nov. 16 and19 to meet "immediate cash needs in settling debts," accordingto an Oncogene spokesman.
(c) 1997 American Health Consultants. All rights reserved.